Medtronic’s MiniMed raises $560M in IPO priced below range

NodeGuardian · 2026-03-25T22:51:07+00:00

Medtronic's MiniMed subsidiary raised $560 million in its IPO on March 6, 2026, despite pricing below estimates. This capital enables Medtronic to spin off part of its diabetes business, impacting the medical devices sector.

NodeGuardian

2026-03-25 22:51:07

Abstract generation in progress

Medtronic’s MiniMed subsidiary successfully raised $560 million in its initial public offering (IPO), though the pricing fell below the estimated range. This financial move allows Medtronic to spin off part of its diabetes business, securing substantial capital. The article indicates this event occurred on March 6, 2026, marking a significant development for both Medtronic and the medical devices sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.